Vericel Corporation’s recent filing unveils that its Director ZERBE ROBERT L MD unloaded Company’s shares for reported $38840.0 on Jul 14. In the deal valued at $38.84 per share,1,000 shares were sold. As a result of this transaction, ZERBE ROBERT L MD now holds 33,395 shares worth roughly $ 1.09 million.
Then, ZERBE ROBERT L MD sold 3,000 shares, generating $108,000 in total proceeds. Upon selling the shares at $36.00, the Director now owns 34,395 shares.
Before that, SIEGAL JONATHAN sold 330 shares. Vericel Corporation shares valued at $10,230 were divested by the Principal Accounting Officer at a price of $31.00 per share. As a result of the transaction, SIEGAL JONATHAN now holds 675 shares, worth roughly $21978.0.
BTIG Research upgraded its Vericel Corporation [VCEL] rating to a Buy from a a Neutral in a research note published on Tuesday. PT values the company’s stock at a premium of 16.51 to its Tuesday closing price.
Price Performance Review of VCEL
On Tuesday, Vericel Corporation [NASDAQ:VCEL] saw its stock fall -3.90% to $32.56. On the same session, the stock had its day’s lowest price of $32.19, but rose to a high of $33.58. Over the last five days, the stock has gained 1.56%. Vericel Corporation shares have risen nearly 23.61% since the year began. Nevertheless, the stocks have risen 32.57% over the past one year. While a 52-week high of $39.90 was reached on 07/19/23, a 52-week low of $17.30 was recorded on 01/06/23. SMA at 50 days reached $35.11, while 200 days put it at $30.61. A total of 0.53 million shares were traded, compared to the trading of 0.26 million shares in the previous session.
Levels Of Support And Resistance For VCEL Stock
The 24-hour chart illustrates a support level at 31.97, which if violated will result in even more drops to 31.39. On the upside, there is a resistance level at 33.36. A further resistance level may holdings at 34.17. The Relative Strength Index (RSI) on the 14-day chart is 44.53, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.51, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.47%. Stochastics %K at 74.06% indicates the stock is a holding.
How much short interest is there in Vericel Corporation?
A steep rise in short interest was recorded in Vericel Corporation stocks on Aug 14, 2023, dropping by -0.21 million shares to a total of 5.36 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 5.57 million shares. There was a decline of -3.92%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 16.28% of the overall stock float, the days-to-cover ratio (short ratio) fell to 12.35.
According to FactSet, Vericel Corporation’s share price will average $41.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 21.02 percent from its previous closing price of $33.88. Analysts expect Vericel Corporation stock to reach the higher price of $44.00, while the lowest price estimate is $39.00. However, 5 analysts have rated VCEL stock as a Buy in their predictions for 2023.